Serotype IV and invasive group B streptococcus disease in neonates, Minnesota, USA, 2000-20101

Emerging Infectious Diseases

Volumn 19, Issue 4, 2013, Pages 553-558

  Ferrieri, Patricia ^a   Lynfield, Ruth ^b   Creti, Roberta ^c   Flore, Aurea E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CLINDAMYCIN; ERYTHROMYCIN; MEMBRANE PROTEIN; POLYSACCHARIDE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CROSS REACTION; DRUG SENSITIVITY; GEOGRAPHIC DISTRIBUTION; GROUP B STREPTOCOCCAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; ANTIBIOTIC RESISTANCE; BACTERIUM; BLOOD; CAPSULAR POLYSACCHARIDE; CLASSIFICATION; CLINDAMYCIN RESISTANCE; CPS; DRUG EFFECT; EARLY-ONSET GBS DISEASE; GBS; GENETICS; GENOTYPE; INFANT; INVASIVE GBS DISEASE; ISOLATION AND PURIFICATION; LATE-ONSET GBS DISEASE; MICROBIOLOGY; NEONATAL GBS DISEASE; NEONATES; NEWBORN; PROPHYLAXIS; RETROSPECTIVE STUDY; SEROTYPE IV; SEROTYPING; STREPTOCOCCI; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

ANTIMICROBIAL RESISTANCE; BACTERIA; CAPSULAR POLYSACCHARIDE; CLINDAMYCIN RESISTANCE; CPS; EARLY-ONSET GBS DISEASE; GBS; GROUP B STREPTOCOCCUS; INVASIVE GBS DISEASE; LATE-ONSET GBS DISEASE; MINNESOTA; NEONATAL GBS DISEASE; NEONATES; PROPHYLAXIS; SEROTYPE; SEROTYPE IV; STREPTOCOCCI; UNITED STATES;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MINNESOTA; MULTILOCUS SEQUENCE TYPING; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84875351985     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1904.121572     Document Type: Article

References (40)

1. Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th ed. Philadelphia: Saunders; 2001. p. 1091-156.
2. Ferrieri P, Wallen L. Neonatal bacterial sepsis. In: Gleason CA, Devaskar S, editors. Avery's diseases of the newborn. 9th ed. Philadelphia: Elsevier/Saunders; 2012. p. 538-50.
3. Guilbert J, Levy C, Cohen R, Bacterial Meningitis Group, Delacourt C, Renolleau S, et al. Late and ultra late onset Streptococcus B meningitis: clinical and bacteriological data over 6 years in France. Acta Paediatr. 2010;99:47-51. http://dx.doi.org/10.1111/j.1651-2227.2009.01510.x
4. Imperi M, Gherardi G, Berardi A, Baldassarri L, Pataracchia M, Dicuonzo G, et al. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Clin Microbiol Infect. 2011;17:1834-9. http://dx.doi.org/10.1111/j.1469-0691.2011.03479.x
5. Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol. 2009;47:1143-8. http://dx.doi.org/10.1128/JCM.01424-08
6. Martins ER, Pessanha MA, Ramirez M, Melo-Cristino J; The Portuguese Group for the Study of Streptococcal Infections. Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol. 2007;45:3224-9. http://dx.doi.org/10.1128/JCM.01182-07
7. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002;51(RR-11):1-22.
8. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, populationbased analysis. Pediatr Infect Dis J. 2008;27:1057-64. http://dx.doi. org/10.1097/INF.0b013e318180b3b9
9. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee M-LT, et al. Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis. 2000;30:276-81. http://dx.doi.org/10.1086/313665
10. Harrison LH, Elliott JA, Dwyer DM, Libonati JP, Ferrieri P, Billmann L, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis. 1998;177:998-1002. http://dx.doi.org/10.1086/515260
11. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep. 1996;45(RR-7):1-24.
12. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299:2056-65. http://dx.doi.org/10.1001/jama.299.17.2056
13. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
14. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, et al. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol. 2007;45:2909-16. http:// dx.doi.org/10.1128/JCM.00999-07
15. Shet A, Ferrieri P. Neonatal & maternal group B streptococcal infections: a comprehensive review. Indian J Med Res. 2004;120:141-50.
16. Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P. Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol. 2010;48:3100-4. http://dx.doi.org/10.1128/JCM.00277-10
17. Slotved H-C, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol. 2007;45:2929-36. http://dx.doi.org/10.1128/JCM.00117-07
18. Ferrieri P, Baker CJ, Hillier SL, Flores AE. Diversity of surface protein expression in group B streptococcal colonizing & invasive isolates. Indian J Med Res. 2004;119(Suppl):191-6.
19. Johnson DR, Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol. 1984;19:506-10.
20. Erdogan S, Fagan PK, Talay SR, Rohde M, Ferrieri P, Flores AE, et al. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci. Infect Immun. 2002;70:803-11. http://dx.doi.org/10.1128/IAI.70.2.803-811.2002
21. Ramaswamy SV, Ferrieri P, Madoff LC, Flores AE, Kumar N, Tettelin H, et al. Identification of novel cps locus polymorphisms in nontypable group B Streptococcus. J Med Microbiol. 2006;55:775-83. http://dx.doi.org/10.1099/jmm.0.46253-0
22. Amundson NR, Flores AE, Hillier SL, Baker CJ, Ferrieri P. DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol. 2005;43:572-6. http://dx.doi.org/10.1128/JCM.43.2.572-576.2005
23. Benson JA, Ferrieri P. Rapid pulsed-field gel electrophoresis method for group B streptococcus isolates. J Clin Microbiol. 2001;39:3006-8. http://dx.doi.org/10.1128/JCM.39.8.3006-3008.2001
24. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan M-S, Kunst F, et al. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol. 2003;41:2530-6. http://dx.doi.org/10.1128/ JCM.41.6.2530-2536.2003
25. Feil EJ, Li B, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2004;186:1518-30. http://dx.doi.org/10.1128/JB.186.5.1518-1530.2004
26. Castor ML, Whitney CG, Como-Sabetti K, Facklam RR, Ferrieri P, Bartkus JM, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol. 2008;2008:727505. http://dx.doi.org/10.1155/2008/727505
27. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AKM, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systemic review and meta-analysis. Lancet. 2012;379:547-56. http://dx.doi.org/10.1016/S0140-6736 (11)61651-6
28. Lin F-YC, Weisman LE, Troendle J, Adams K. Prematurity is the major risk factor for late-onset group B streptococcus disease. J Infect Dis. 2003;188:267-71. http://dx.doi.org/10.1086/376457
29. Hamada S, Vearncombe M, McGeer A, Shah PS. Neonatal group B streptococcal disease: incidence, presentation, and mortality. J Matern Fetal Neonatal Med. 2008;21:53-7. http://dx.doi. org/10.1080/14767050701787474
30. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360:2626-36. http:// dx.doi.org/10.1056/NEJMoa0806820
31. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364:2016-25. http://dx.doi.org/10.1056/ NEJMoa1005384
32. Puopolo KM, Madoff LC. Type IV neonatal early-onset group B streptococcal disease in a United States hospital. J Clin Microbiol. 2007;45:1360-2. http://dx.doi.org/10.1128/JCM.02487-06
33. Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996;173:365-73. http://dx.doi. org/10.1093/infdis/173.2.365
34. Elliott JA, Farmer KD, Facklam RR. Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol. 1998;36:2115-6.
35. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol. 2003;101:74-9. http://dx.doi.org/10.1016/S0029-7844(02)02452-3
36. Kothari NJ, Morin CA, Glennen A, Jackson D, Harper J, Schrag SJ, et al. Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003-2007. Emerg Infect Dis. 2009;15:1279-81. http:// dx.doi.org/10.3201/eid1508.081381
37. Koenig JM, Keenan WJ. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatr Clin North Am. 2009;56:689-708. http://dx.doi.org/10.1016/j.pcl.2009.04.003
38. Luan S-L, Granlund M, Sellin M, Lagergård T, Spratt BG, Norgren M. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol. 2005;43:3727-33. http:// dx.doi.org/10.1128/JCM.43.8.3727-3733.2005
39. Martins ER, Andreu A, Correia P, Juncosa T, Bosch J, Ramirez M, et al. Group B streptococci causing neonatal infections in Barcelona are a stable clonal population: 18-year surveillance. J Clin Microbiol. 2011;49:2911-8. http://dx.doi.org/10.1128/JCM.00271-11
40. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012;30:4123-6. http://dx.doi.org/10.1016/j. vaccine.2012.04.048